Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference